Found: 3
Select item for more details and to access through your institution.
EP300/TP53 pathway, a suppressor of the Hippo and canonical WNT pathways, is activated in human hearts with arrhythmogenic cardiomyopathy in the absence of overt heart failure.
- Published in:
- Cardiovascular Research, 2022, v. 118, n. 6, p. 1466, doi. 10.1093/cvr/cvab197
- By:
- Publication type:
- Article
Haploinsufficiency of Tmem43 in cardiac myocytes activates the DNA damage response pathway leading to a late-onset senescence-associated pro-fibrotic cardiomyopathy.
- Published in:
- Cardiovascular Research, 2021, v. 117, n. 11, p. 2377, doi. 10.1093/cvr/cvaa300
- By:
- Publication type:
- Article
Exercise restores dysregulated gene expression in a mouse model of arrhythmogenic cardiomyopathy.
- Published in:
- Cardiovascular Research, 2020, v. 116, n. 6, p. 1199, doi. 10.1093/cvr/cvz199
- By:
- Publication type:
- Article